NEW YORK, Oct. 23 – DeCode Genetics has used data gleaned from its population genomics research of patients in Iceland with Parkinson’s disease to map the first gene linked to the main form of the disease, the company said on Tuesday.

The next step, the firm said, is to develop DNA-based diagnostics and drugs to treat the disorder.

The discovery also served to challenge the widely held notion that there is no identifiable genetic component that contributes to the development of the disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.